New York State Teachers Retirement System Vertex Pharmaceuticals Inc Transaction History

New York State Teachers Retirement System

$48.5 Billion
Q3 2024

A detailed history of New York State Teachers Retirement System transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, New York State Teachers Retirement System holds 231,981 shares of VRTX stock, worth $108 Million. This represents 0.22% of its overall portfolio holdings.

Number of Shares

231,981

Previous 255,596 9.24%

Holding current value

$108 Million

Previous $120 Million 9.94%

% of portfolio

0.22%

Previous 0.25%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 25, 2024	SELL	$460.0 - $505.78 $10.9 Million - $11.9 Million	-23,615 Reduced 9.24%	231,981 $108 Million
Q2 2024 Jul 24, 2024	SELL	$392.81 - $485.53 $4.21 Million - $5.2 Million	-10,706 Reduced 4.02%	255,596 $120 Million
Q1 2024 Apr 25, 2024	SELL	$407.69 - $446.08 $2.6 Million - $2.85 Million	-6,388 Reduced 2.34%	266,302 $111 Million
Q4 2023 Jan 24, 2024	SELL	$343.0 - $410.68 $2.42 Million - $2.9 Million	-7,062 Reduced 2.52%	272,690 $111 Million
Q3 2023 Oct 25, 2023	SELL	$338.18 - $362.46 $3.6 Million - $3.85 Million	-10,634 Reduced 3.66%	279,752 $97.3 Million
Q2 2023 Jul 27, 2023	SELL	$314.42 - $351.91 $2.79 Million - $3.12 Million	-8,863 Reduced 2.96%	290,386 $102 Million
Q1 2023 Apr 27, 2023	SELL	$283.23 - $323.1 $3.05 Million - $3.48 Million	-10,761 Reduced 3.47%	299,249 $94.3 Million
Q4 2022 Jan 27, 2023	SELL	$285.76 - $321.48 $1.46 Million - $1.64 Million	-5,100 Reduced 1.62%	310,010 $89.5 Million
Q3 2022 Oct 28, 2022	SELL	$273.83 - $305.53 $2.23 Million - $2.49 Million	-8,158 Reduced 2.52%	315,110 $91.2 Million
Q1 2022 Apr 27, 2022	SELL	$221.42 - $260.97 $283,417 - $334,041	-1,280 Reduced 0.39%	323,268 $84.4 Million
Q4 2021 Jan 24, 2022	SELL	$177.01 - $223.45 $704,145 - $888,884	-3,978 Reduced 1.21%	324,548 $71.3 Million
Q3 2021 Oct 25, 2021	SELL	$181.39 - $202.99 $2.38 Million - $2.66 Million	-13,108 Reduced 3.84%	328,526 $59.6 Million
Q2 2021 Jul 21, 2021	SELL	$187.49 - $221.1 $2.49 Million - $2.93 Million	-13,268 Reduced 3.74%	341,634 $68.9 Million
Q1 2021 Apr 22, 2021	SELL	$207.02 - $241.31 $2.08 Million - $2.42 Million	-10,036 Reduced 2.75%	354,902 $76.3 Million
Q4 2020 Jan 25, 2021	BUY	$207.01 - $276.09 $718,945 - $958,860	3,473 Added 0.96%	364,938 $86.2 Million
Q3 2020 Nov 06, 2020	SELL	$255.65 - $303.1 $3.02 Million - $3.58 Million	-11,826 Reduced 3.17%	361,465 $0
Q2 2020 Jul 21, 2020	BUY	$225.48 - $295.8 $1.59 Million - $2.08 Million	7,032 Added 1.92%	373,291 $108 Million
Q1 2020 Apr 29, 2020	BUY	$199.77 - $247.81 $19,977 - $24,781	100 Added 0.03%	366,259 $87.2 Million
Q4 2019 Jan 24, 2020	BUY	$166.71 - $223.91 $201,218 - $270,259	1,207 Added 0.33%	366,159 $80.2 Million
Q3 2019 Oct 24, 2019	SELL	$166.23 - $187.09 $123,675 - $139,194	-744 Reduced 0.2%	364,952 $61.8 Million
Q2 2019 Jul 18, 2019	SELL	$164.61 - $190.37 $1.28 Million - $1.48 Million	-7,789 Reduced 2.09%	365,696 $67.1 Million
Q1 2019 May 07, 2019	BUY	$163.73 - $194.7 $663,761 - $789,313	4,054 Added 1.1%	373,485 $68.7 Million
Q4 2018 Jan 28, 2019	SELL	$151.91 - $192.21 $1.35 Million - $1.71 Million	-8,900 Reduced 2.35%	369,431 $61.2 Million
Q3 2018 Nov 02, 2018	SELL	$167.73 - $192.74 $860,958 - $989,334	-5,133 Reduced 1.34%	378,331 $72.9 Million
Q2 2018 Aug 01, 2018	SELL	$145.72 - $169.96 $895,012 - $1.04 Million	-6,142 Reduced 1.58%	383,464 $65.2 Million
Q1 2018 May 01, 2018	SELL	$151.6 - $177.13 $657,792 - $768,567	-4,339 Reduced 1.1%	389,606 $63.5 Million
Q4 2017 Feb 12, 2018	BUY	$137.28 - $155.55 $6,726 - $7,621	49 Added 0.01%	393,945 $59 Million
Q3 2017 Oct 30, 2017	BUY	$148.13 - $162.24 $739,020 - $809,415	4,989 Added 1.28%	393,896 $59.9 Million
Q2 2017 Aug 11, 2017	BUY	N/A	388,907	388,907 $50.1 Million

Others Institutions Holding VRTX

# of Institutions

1,724

Shares Held

222M

Call Options Held

1.58M

Put Options Held

1.36M

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $119B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of New York State Teachers Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on New York State Teachers Retirement System with notifications on news.

Account

New York State Teachers Retirement System Vertex Pharmaceuticals Inc Transaction History